3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
February 1, 2008 - Abbott has received reimbursement approval in France for its XIENCE V Everolimus Eluting Coronary ...
January 31, 2008
December 6, 2007 — The Circulatory System Devices Advisory Panel to the FDA has recommended approval for the XIENCE V ...
December 05, 2007December 4, 2007 - Patients treated with Abbott Laboratories Inc.’s experimental drug-coated heart stent had low rates ...
December 03, 2007November 5, 2007 - New data released today at the American Heart Association's Scientific Sessions showed that Abbott's ...
November 05, 2007October 25, 2007 — Two carotid stenting trials examining outcomes in real-world patients demonstrated for the first time ...
October 24, 2007October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events ...
October 22, 2007OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease ...
October 22, 2007October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the ...
October 17, 2007October 2, 2007 - Abbott said the FDA has granted waived status under the Clinical Laboratory Improvement Amendments of ...
October 01, 2007September 25, 2007 - Abbott enrolled the first patient in HERCULES (Herculink Elite Cobalt Chromium Renal Stent Trial to ...
September 24, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now